Cost-effectiveness of Varying 10-Year Risk Statin Treatment Thresholds
Interview with Thomas A. Gaziano, MD, MSc, author of Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.